Adastra Holdings Announces 2021 Annual Financial Results and Corporate Update

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Announces 2021 Annual Financial Results and Corporate Update2023-01-27T21:30:47+00:00

Adastra Announces Submission of Medical Sales License Application and Engagement of IR Labs Inc. to Provide Investor Relations Services

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Announces Submission of Medical Sales License Application and Engagement of IR Labs Inc. to Provide Investor Relations Services2023-01-27T21:30:47+00:00

Adastra Announces Successful Soft Launch of Endgame Brand in BC

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Announces Successful Soft Launch of Endgame Brand in BC2023-01-27T21:30:47+00:00

Adastra Announces a Record Production Month and Management Changes

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Announces a Record Production Month and Management Changes2023-01-27T21:30:47+00:00

Adastra Announces Completed Submission of Controlled Substances Dealer’s License Application

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Announces Completed Submission of Controlled Substances Dealer’s License Application2023-01-27T21:30:47+00:00

Adastra Holdings Announces Co-Manufacturing Partnership to bring Zyre Brands to Market

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Announces Co-Manufacturing Partnership to bring Zyre Brands to Market2023-01-27T21:30:47+00:00

Final Adastra Holdings Expands Co-Manufacturing Portfolio and Provides Facility Expansion Update

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Final Adastra Holdings Expands Co-Manufacturing Portfolio and Provides Facility Expansion Update2023-01-27T21:30:47+00:00

Adastra Holdings Receives Flower Sales License from Health Canada

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Receives Flower Sales License from Health Canada2023-01-27T21:30:47+00:00

Adastra Holdings Reports Record Third Quarter Results

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Reports Record Third Quarter Results2023-01-27T21:30:47+00:00

Adastra Holdings Provides Product Growth Update and Announces Insider Open-Market Stock Purchases

LANGLEY, BC / August 23, 2021

Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) (FRA: D2EP) (the “Company”) is pleased to announce that, further to its news releases of March 10, 2021 and March 23, 2021, the Company continues to proceed towards the acquisition of 1204581 B.C. Ltd, doing business as Phyto Extractions.
Adastra Holdings Provides Product Growth Update and Announces Insider Open-Market Stock Purchases2023-01-27T21:30:47+00:00
Go to Top